Association of baseline ctDNA EGFR mutation detection with clinical outcome in the phase II RAMOSE trial assessing ramucirumab plus osimertinib versus osimertinib in EGFR mutant non-small cell lung cancer
Publication Title
AACR Annual Meeting; April 25-30; Chicago, IL 2025: 3776.
Document Type
Article
Publication Date
4-2025
Keywords
oregon; chiles
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
Comments
Heeke S, Duose D, Arjuna S, Nilsson M, Patel J, Shum E, Baik C, Sanborn R, Shu C, Kim C, Fidler MJ, Hall R, Gray J, Saltos A, Heymach JV, Le X.